参考文献

[1] Austin G L, Ogden L G, Hill J O. Trends in carbohydrate, fat, and protein intakes and association with energy intake in normal-weight, overweight, and obese individuals: 1971-2006. Am J Clin Nutr, 2011, 93（4）: 836-843.

[2] Bilton R. Averting comfortable lifestyle crises. Sci Prog, 2013, 96（Pt 4）: 319-368.

[3] Poudyal H, Brown L. Should the pharmacological actions of dietary fatty acids in cardiometabolic disorders be classified based on biological or chemical function? Prog Lipid Res, 2015, 59: 172-200.

[4] Lamarche B, Couture P. Dietary fatty acids, dietary patterns, and lipoprotein metabolism. Curr Opin Lipidol, 2015, 26（1）: 42-47.

[5] Yanai H, et al. Effects of intake of fish or fish oils on the development of diabetes. J Clin Med Res, 2015, 7（1）: 8-12.

[6] Wood L G. Omega-3 polyunsaturated fatty acids and chronic obstructive pulmonary disease. Curr Opin Clin Nutr Metab Care, 2015, 18（2）: 128-132.

[7] Witte T R, Hardman W E. The effects of omega-3 polyunsaturated Fatty Acid consumption on mammary carcinogenesis. Lipids, 2015, 50（5）: 437-446.

[8] Tvrzicka E, et al. Fatty acids as biocompounds: their role in human metabolism, health and diseasea review. Part 1: classification, dietary sources and biological functions. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2011, 155（2）: 117-130.

[9] Hur K Y, Lee M S. Gut Microbiota and Metabolic Disorders. Diabetes Metab J, 2015, 39（3）: 198-203.

[10] Aldunate M, et al. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol, 2015, 6: 164.

[11] MacFabe D F. Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders. Microb Ecol Health Dis, 2015, 26: 28177.

[12] Sekiguchi H, et al. A novel antidiabetic therapy: free fatty acid receptors as potential drug target. Curr Diabetes Rev, 2015, 11（2）: 107-115.

[13] Mohammad S. Role of Free Fatty Acid Receptor 2 （FFAR2） in the Regulation of Metabolic Homeostasis. Curr Drug Targets, 2015, 16（7）: 771-775.

[14] Kasubuchi M, et al. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients, 2015, 7（4）: 2839-2849.

[15] Janssen A W, Kersten S. The role of the gut microbiota in metabolic health. Faseb J, 2015, 29（8）: 3111-3123.

[16] Ribas G S, Vargas C R, Wajner M. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Gene, 2014, 533（2）: 469-476.

[17] Ichimura A, Hara T, Hirasawa A. Regulation of Energy Homeostasis via GPR120. Front Endocrinol （Lausanne）, 2014, 5: 111.

[18] Huang H, Dai M H, Tao Y X. Physiology and therapeutics of the free fatty acid receptor GPR40. Prog Mol Biol Transl Sci, 2014, 121: 67-94.

[19] Yonezawa T, et al. Free fatty acids-sensing G protein-coupled receptors in drug targeting and therapeutics. Curr Med Chem, 2013, 20（31）: 3855-3871.

[20] Zhu M, Li X. Meta-analysis of structured triglyceride versus other lipid emulsions for parenteral nutrition. Nutrition, 2013, 29（6）: 833-840.

[21] Lee Y Y, Tang T K, Lai O M. Health benefits, enzymatic production, and application of medium and long-chain triacylglycerol （MLCT） in food industries: a review. J Food Sci, 2012, 77（8）: R137-R144.

[22] Zugasti Murillo A, Petrina Jauregui E, Elizondo Armendariz J. Parenteral nutrition-associated liver disease and lipid emulsions. Endocrinol Nutr, 2015, 62（6）: 285-289.

[23] Fattore E, et al. Palm oil and blood lipid-related markers of cardiovascular disease: a systematic review and meta-analysis of dietary intervention trials. Am J Clin Nutr, 2014, 99（6）: 1331-1350.

[24] Sales-Campos H, et al. An overview of the modulatory effects of oleic acid in health and disease. Mini Rev Med Chem, 2013, 13（2）: 201-210.

[25] Calton E K, et al. Certain dietary patterns are beneficial for the metabolic syndrome: reviewing the evidence. Nutr Res, 2014, 34（7）: 559-568.

[26] Krishnan S, Cooper J A. Effect of dietary fatty acid composition on substrate utilization and body weight maintenance in humans. Eur J Nutr, 2014, 53（3）: 691-710.

[27] Khodarahmi M, Azadbakht L. The association between different kinds of fat intake and breast cancer risk in women. Int J Prev Med, 2014, 5（1）: 6-15.

[28] Lang U E, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem, 2013, 31（6）: 761-777.

[29] Siriwardhana N, et al. Modulation of adipose tissue inflammation by bioactive food compounds. J Nutr Biochem, 2013, 24（4）: 613-623.

[30] Lopez S, et al. Membrane composition and dynamics: a target of bioactive virgin olive oil constituents. Biochim Biophys Acta, 2014, 1838（6）: 1638-1656.

[31] Wendlinger C, Hammann S, Vetter W. Various concentrations of erucic acid in mustard oil and mustard. Food Chem, 2014, 153: 393-397.

[32] Shu Y, et al. Interaction of erucic acid with bovine serum albumin using a multi-spectroscopic method and molecular docking technique. Food Chem, 2015, 173: 31-37.

[33] Vucic V, et al. Trans fatty acid content in Serbian margarines: Urgent need for legislative changes and consumer information. Food Chem, 2015, 185: 437-440.

[34] Trattner S, et al. Fatty acid composition of Swedish bakery products, with emphasis on trans-fatty acids. Food Chem, 2015, 175: 423-430.

[35] Hendry V L, et al. Impact of regulatory interventions to reduce intake of artificial trans-fatty acids: a systematic review. Am J Public Health, 2015, 105（3）: e32-e42.

[36] Mennitti L V, et al. Type of fatty acids in maternal diets during pregnancy and/or lactation and metabolic consequences of the offspring. J Nutr Biochem, 2015, 26（2）: 99-111.

[37] Ganguly R, Pierce G N. The toxicity of dietary trans fats. Food Chem Toxicol, 2015, 78: 170-176.

[38] Takkunen M J, et al. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study. Eur J Nutr，， 2016, 55（3）: 967-979.

[39] Pase C S, et al. Chronic consumption of trans fat can facilitate the development of hyperactive behavior in rats. Physiol Behav, 2015, 139: 344-350.

[40] Werlein A, et al. Interference of phosphatidylcholines with in-vitro cell proliferation-no flock without black sheep. Biochim Biophys Acta, 2015, 1848（7）: 1599-1608.

[41] Kajla P, Sharma A, Sood D R. Flaxseed-a potential functional food source. J Food Sci Technol, 2015, 52（4）: 1857-1871.

[42] Poniedzialek-Czajkowska E, et al. Polyunsaturated fatty acids in pregnancy and metabolic syndrome: a review. Curr Pharm Biotechnol, 2014, 15（1）: 84-99.

[43] Muller C P, et al. Brain membrane lipids in major depression and anxiety disorders. Biochim Biophys Acta, 2015, 1851（8）: 1052-1065.

[44] Yurko-Mauro K, Alexander D D, Van Elswyk M E. Docosahexaenoic acid and adult memory: a systematic review and meta-analysis. PLoS One, 2015, 10（3）: e0120391.

[45] Astarita G, et al. Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids. Biochim Biophys Acta, 2015, 1851（4）: 456-468.

[46] Yuan G, Chen X, Li D. Modulation of peroxisome proliferator-activated receptor gamma （PPAR gamma） by conjugated fatty acid in obesity and inflammatory bowel disease. J Agric Food Chem, 2015, 63（7）: 1883-1895.

[47] Varin A, et al. Liver X receptor activation promotes polyunsaturated fatty acid synthesis in macrophages: relevance in the context of atherosclerosis. Arterioscler Thromb Vasc Biol, 2015, 35（6）: 1357-1365.

[48] Brejning J, et al. Loss of NDG-4 extends lifespan and stress resistance in Caenorhabditis elegans. Aging Cell, 2014, 13（1）: 156-164.

[49] Jeon T I, Osborne T F. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab, 2012, 23（2）: 65-72.

[50] de Castro G S, et al. Fish oil decreases hepatic lipogenic genes in rats fasted and refed on a high fructose diet. Nutrients, 2015, 7（3）: 1644-1656.

[51] Liu H D, et al. FFA4 receptor （GPR120）: A hot target for the development of anti-diabetic therapies. Eur J Pharmacol, 2015, 763: 160-168.

[52] Urquhart P , Nicolaou A, Woodward D F. Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases. Biochim Biophys Acta, 2015, 1851（4）: 366-376.

[53] Kremmyda L S, et al. Fatty acids as biocompounds: their role in human metabolism, health and disease: a review. part 2: fatty acid physiological roles and applications in human health and disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2011, 155（3）: 195-218.

[54] Walker J M, Harrison F E．Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer’s Disease: Impacts on Cognitive Decline. Nutrients, 2015, 7（9）: 7332-7357.

[55] Serhan C N, Chiang N, Dalli J. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. Semin Immunol, 2015, 27（3）: 200-215.

[56] Wu S, et al. Omega-3 free fatty acids inhibit tamoxifen-induced cell apoptosis. Biochem Biophys Res Commun, 2015, 459（2）: 294-299.

[57] Begum G, et al. Docosahexaenoic acid reduces ER stress and abnormal protein accumulation and improves neuronal function following traumatic brain injury. J Neurosci, 2014, 34（10）: 3743-3755.

[58] Bhaswant M, Poudyal H, Brown L. Mechanisms of enhanced insulin secretion and sensitivity with n-3 unsaturated fatty acids. J Nutr Biochem, 2015, 26（6）: 571-584.

[59] Papandreou D, Andreou E. Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World J Hepatol, 2015, 7（3）: 575-582.

[60] Kim Y S, Xun P, He K. Fish consumption, long-chain omega-3 polyunsaturated fatty acid intake and risk of metabolic syndrome: a meta-analysis. Nutrients, 2015, 7（4）: 2085-2100.

[61] Lorente-Cebrian S, et al. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. J Physiol Biochem, 2015, 71（2）: 341-349.

[62] Marventano S, et al. A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter? Int J Food Sci Nutr, 2015, 66: 611-622.

[63] Azrad M, Turgeon C, Demark-Wahnefried W．Current evidence linking polyunsaturated Fatty acids with cancer risk and progression. Front Oncol, 2013, 3: 224.

[64] Khandelwal S, et al. Impact of omega-6 fatty acids on cardiovascular outcomes: A review. J Preventive Cardiol, 2013, 2（3）: 325-336.

[65] Wu J H, et al. Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study. Circulation, 2014, 130（15）: 1245-1253.

[66] Ramsden C E, et al. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr, 2010, 104（11）: 1586-1600.

[67] Harris W. Omega-6 and omega-3 fatty acids: partners in prevention. Curr Opin Clin Nutr Metab Care, 2010, 13（2）: 125-129.

[68] Ooi E M, et al. Dietary fatty acids and lipoprotein metabolism: new insights and updates. Curr Opin Lipidol, 2013, 24（3）: 192-197.

[69]Muhlhausler B S, Ailhaud G P. Omega-6 polyunsaturated fatty acids and the early origins of obesity. Curr Opin Endocrinol Diabetes Obes, 2013, 20（1）: 56-61.

[70] Xu Y, Qian S Y. Anti-cancer activities of omega-6 polyunsaturated fatty acids. Biomed J, 2014, 37（3）: 112-119.

[71] Russo G L. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol, 2009, 77（6）: 937-946.

[72] Shingfield K J, Bonnet M, Scollan N D. Recent developments in altering the fatty acid composition of ruminant-derived foods. Animal, 2013, 7 Suppl 1: 132-162.

[73] Abuajah C I, Ogbonna A C, Osuji C M. Functional components and medicinal properties of food: a review. J Food Sci Technol, 2015, 52（5）: 2522-2529.

[74] Tsuduki T. Research on food and nutrition characteristics of conjugated fatty acids. Biosci Biotechnol Biochem, 2015, 79（8）: 1217-1222.

[75] Calder P C. Long chain fatty acids and gene expression in inflammation and immunity. Curr Opin Clin Nutr Metab Care, 2013, 16（4）: 425-433.

[76] Afonso Mda S, et al. The impact of dietary fatty acids on macrophage cholesterol homeostasis. J Nutr Biochem, 2014, 25（2）: 95-103.

[77] Moon H S. Biological effects of conjugated linoleic acid on obesity-related cancers. Chem Biol Interact, 2014, 224C: 189-195.

[78] Visioli F, et al. Molecular targets of omega 3 and conjugated linoleic Fatty acids-“micromanaging” cellular response. Front Physiol, 2012, 3: 42.